In the diagnosis of benign prostatic hyperplasia it is important to find the origin of the problems and to rule out, above all, a bladder tumor.
Secondly, it is necessary to understand the extent of the disease, its severity and possible complications in order to establish the best possible diagnosis and treat it appropriately. We measure the symptoms through a questionnaire, perform a physical examination to assess the size, shape and consistency of the prostate and perform urine and blood tests.
The diagnosis of benign prostatic hyperplasia is complex because of the interrelationship of the prostate with adjacent organs and the unspecificity of the symptoms. It is essential to ascertain the origin of the problems and to rule out, above all, bladder tumor. Secondly, it will be necessary to understand the extent of prostate problems, their severity and possible complications in order to establish the best possible diagnosis and attack it with the most appropriate treatment.
Generally, we establish three levels of diagnosis:
Thus, the diagnosis begins with an assessment of your medical history and the performance of a series of questions and tests:
To rule out the presence of a bladder tumor, urethral stricture, urinary tract infection, bladder lithiasis or overactive bladder, tests such as renovesicoprostatic ultrasound and urinary cytology will be performed. In this sense, urethrocystoscopy can be useful if there is suspicion of urethral stricture or the presence of a bladder tumor -by ultrasound or after an abnormal cytology-.
Once the above is ruled out, it will be determined whether benign prostatic hyperplasia may be producing complications secondary to obstruction, such as bladder lithiasis, repeated urinary tract infections, chronic urinary retention, hydronephrosis or the presence of chronic renal insufficiency. For this purpose, we rely on ultrasound and the performance of a blood test in which we determine renal function.
In addition, the risk of prostate disease progression will be calculated using PSA and prostate volume (by ultrasound). Men with a prostate larger than 40cc and PSA >1.5 have a higher risk of symptom progression at five years and will require more intensive treatment. In those with smaller prostates or lower PSA, especially if they have fewer symptoms, we can be more conservative with treatment.
Finally, tests are performed to help detect bladder obstruction. The simplest of these is urinary flowmetry, which allows the volume of urine per unit of time to be measured.
In cases where more diagnostic power is needed, urodynamics can be performed. This is a more invasive test performed by inserting a small bladder and rectal catheter to measure bladder and abdominal pressures.
Benign prostatic hyperplasia (BPH) is not a cancer nor does it increase the risk of developing it, therefore, it is not a dangerous disease in itself. However, if not treated properly, it can lead to major complications that do seriously affect health and quality of life. Among the possible consequences of uncontrolled BPH are: acute urinary retention (inability to urinate), recurrent urinary tract infections, bladder stone formation, progressive damage to the bladder or kidneys. Therefore, although it is not malignant, it does require medical attention and urological follow-up. With early diagnosis and appropriate treatment, BPH can be effectively controlled and complications avoided.
Not at all. In recent years we have more and more technology that allows us to perform minimally invasive prostate surgery without causing sexual side effects.
Yes, very much so. Prostate problems can lead to impotence and premature ejaculation. That's why sometimes early treatment of prostate hyperplasia can prevent you from developing sexual problems.
It is good to drink at least 2 liters of water a day and avoid foods high in saturated fats, condiments, spices and pepper. It is also advisable to reduce the intake of coffee and alcohol, especially white drinks and beer.
Initial experience with thulium fiber laser for prostate enucleation: Analysis of the intraoperative and short-term outcomes in a prospective, multicenter cohort.
ROC Clinic has performed more than 3,000 prostate enucleation procedures with Holmium laser.
Programming of the 2022 courses in Holmium laser prostatic enucleation.